Gentaur Donanemab – Anti-APP Antibody
Targets amyloid precursor protein (APP), used in Alzheimer’s disease research, amyloid clearance, and neurodegeneration assays.
Our latest content
Check out what's new in our company !
Your Dynamic Snippet will be displayed here... This message is displayed because you did not provide both a filter and a template to use.